MissionIR Articles
Original content written and distributed as part of our ongoing relationships.
-
MissionIRNewsBreaks — Cepton Inc. (NASDAQ: CPTN) Reports Financial Numbers, Business Updates for Q3 2022
Cepton (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance lidar solutions, is reporting its third-quarter 2022 results. Highlights of the financial report include a 171% increase in product revenue, which totaled $1.8 million, and…
-
Freight Technologies Inc. (NASDAQ: FRGT) Offers Cloud-Based Technology Solutions to Simplify Over-The-Road Trade Avenues Across USMCA Marketplace
The United States is still the world’s largest economy and largest importer and exporter of goods and services – with strong ties to Mexico and Canada Mexico has reached number one as a US trade…
-
Flora Growth Corp. (NASDAQ: FLGC) Defines Path to Profitability and Portfolio Expansion with Proposed Franchise Global Health Inc. Acquisition
Flora Growth signed a definitive agreement with FGH to acquire 100% of all issued and outstanding shares by way of a statutory plan of agreement The deal is expected to close in December following the…
-
MissionIRNewsBreaks – Knightscope Inc. (NASDAQ: KSCP) Inks New 22-Device Contract with Florida College
Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots (“ASRs”), has signed an agreement to deploy 22 K1 Blue Light Towers at a Florida college. According to the announcement, many schools are ill-equipped to…
-
MissionIRNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Commences 1st-Ever Study Evaluating DehydraTECH-CBD’s Effect on Diabetes
Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, has announced that study program DIAB-A22-1 is expected to begin on schedule today. According to the announcement, this is Lexaria’s first-ever study to…
-
Lexaria Bioscience Corp. (NASDAQ: LEXX) Aiming to Address Unmet Patient Needs of Hypertensive Patients
Lexaria just completed its HYPER-H21-4 human clinical hypertension study, posting a sustained drop in blood pressure in normally active hypertensive patients With the success of this study, the company is working towards an IND application…
-
Rising Investment In Clean Energy Drives Optimism for Correlate Infrastructure Partners Inc. (CIPI)
Nearly a decade has passed since the Paris Accords established international cooperation on curbing fossil fuel pollutants believed to be responsible for adversely affecting the earth’s climate, and some agencies worry that not enough is…
-
MissionIRNewsBreaks – CNS Pharmaceuticals Inc.’s (NASDAQ: CNSP) Targeted ‘Finish Line Is Within Sight’ as It Pursues Potential GBM Treatment
CNS Pharmaceuticals (NASDAQ: CNSP) has been developing drug candidates for treating primary and metastatic brain and central nervous system cancer. “Berubicin, the company’s lead drug candidate, is a novel anthracycline in an ongoing international trail…
-
MissionIRNewsBreaks – Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) Announces Q3-2022 Results, Continued Strengthening of Leading Position in Uranium, Rare Earth Elements
Energy Fuels (NYSE American: UUUU) (TSX: EFR) announced its financial results for the quarter ended Sept. 30, 2022. Among the highlights, the company reported a robust balance sheet with $122.3 million of working capital as…
-
MissionIRNewsBreaks — Cepton Technologies Inc. (NASDAQ: CPTN) Partner with Leading Entities to Complete Project Resulting in Enhanced Road Safety
Cepton Technologies (NASDAQ: CPTN), a Silicon Valley innovator of high-performance lidar solutions, has joined with two other leading companies to complete a proof-of-concept project confirming that an integrated system has the ability to warn drivers…
-
MissionIRNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Featured in Cleantech and Climate Change Podcast
Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, was featured in a new edition of the Cleantech and Climate Change Podcast issued by Investorideas.com, a global news source and leading investor resource covering…
-
MissionIRNewsBreaks – BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Featured in Investment Research Report
BiondVax (NASDAQ: BVXV), a biotechnology company focused on developing, manufacturing and commercializing innovative products for the prevention and treatment of infectious diseases and other illnesses, was featured in a recent report published by Zacks Small-Cap…
-
BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Is ‘One to Watch’
BiondVax has an exclusive worldwide license to commercialize NanoAbs for the treatment of COVID-19 The company plans to initiate a Phase 1/2a clinical trial of its inhaled COVID-19 therapeutic NanoAb in 2023 BiondVax has exclusive…
-
Flora Growth Corp. (NASDAQ: FLGC) Agreement to Acquire Multi-national Cannabis Operator Positions Company for New Strategic Growth in Europe
Flora Growth is a cannabis cultivator and international brand developer with a strong base of operations at its licensed facility in northern Colombia Flora recently announced its plans to acquire multi-national operator Franchise Global Health…
-
MissionIRNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Increasing Access to Safe, Legal CBD and THC to Global Consumers
Flora Growth Corp. (NASDAQ: FLGC) is a cannabis cultivator, brand manufacturer and global distributor. “The Canadian company with a productive base of operations in Colombia’s fertile greenbelt is licensed to cultivate cannabis on a 100-hectare…
-
MissionIRNewsBreaks – Golden Matrix Group Inc. (NASDAQ: GMGI) Announces Full Acquisition of Interest in RKings Competitions
Golden Matrix Group (NASDAQ: GMGI), a developer and licensor of gaming platforms, systems and gaming content, has acquired the remaining 20% interest in RKings Competitions; the company now owns a total of 165,444 restricted shares…
-
Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Zero Adverse Effects from Successful HYPER-H21-4 Study of DehydraTECH(TM)-CBD for High Blood Pressure
The CDC reported more than 670,000 annual deaths in the United States with high blood pressure as a primary or contributing cause Lexaria’s patented DehydraTECH(TM) technology has been shown, through HYPER-H21-4 study, to decrease high…
-
Silo Pharma Inc. (NASDAQ: SILO) Extends Columbia University Agreement to Continue Research for Therapeutics to Treat Alzheimer’s Disease
Silo recently extended Columbia University agreement to continue research for novel therapeutics to treat Alzheimer’s disease and stress-induced anxiety disorder Preclinical studies demonstrate Silo’s jointly-developed Z-pod(TM) delivery technology holds and distributes therapeutics in a time-released…
-
Buildings are Proving Integral to the Energy Transition, and Correlate Infrastructure Partners Inc. (CIPI) is Looking to solve the Challenge of Retrofitting Them to Meet Net Zero Carbon Goals
Commercial buildings in the United States consume 35% of all electricity in the country while accounting for 16% of emissions in the country. Buildings, in general, account for over 60% of emissions, with large business…
-
MissionIRNewsBreaks – EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQX: EVGIF) Benefiting as Utilities Look to Reduce Dependence on Fossil Fuels
EverGen (TSX.V: EVGN) (OTCQX: EVGIF), a leading Canadian renewable energy company and Canada’s renewable natural gas (“RNG”) infrastructure platform, is among companies that are rising to the challenge to provide RNG solutions for utilities increasingly…
-
MissionIRNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Confident in Preclinical Work on Its Novel Ketamine Formulation
Silo Pharma (NASDAQ: SILO), a developmental-stage biopharmaceutical company, is focused on fusing traditional therapeutics with psychedelic research to provide novel treatments for numerous indications, including post-traumatic stress disorder (“PTSD”), fibromyalgia, Alzheimer’s disease, and other rare…
-
MissionIRNewsBreaks – RYVYL Inc. (NASDAQ: RVYL) Announces Plans to Report Q3 2022 Financial Results
RYVYL (NASDAQ: RVYL), a company that leverages the security of the blockchain and USD-pegged stablecoin technology with near-real-time attestation to conduct payment transactions, is planning to release its third quarter 2022 financial report this month.…
-
MissionIRNewsBreaks – Cepton Inc. (NASDAQ: CPTN) to Participate in 13th Craig-Hallum Alpha Select Conference
Cepton (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance lidar solutions, today announced that its Chief Executive Officer Dr. Jun Pei and Chief Financial Officer Hull Xu will be participating in the 13th…
-
MissionIRNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Announces Participation Schedule for Upcoming Investor Events
Cybin (NYSE American: CYBN) (NEO: CYBN), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics(R), today announced its participation in upcoming investor events. The company’s Chief Executive Officer Doug Drysdale will present and host investor…
-
MissionIRNewsBreaks – Golden Matrix Group Inc. (NASDAQ: GMGI) Distinctive in Highly Competitive Online Gambling Space
Golden Matrix (NASDAQ: GMGI), a developer and licensor of online gaming platforms, systems and gaming content, white labels its industry-leading GM-AG System that can be custom-built from 10,000+ game options for its roughly 650 clients…
-
Cannabis Regulation in the Spotlight During Midterm Elections at the Heels of Presidential Pardon; Flora Growth Corp. (NASDAQ: FLGC) Leveraging Colombian Stance to Manufacture Products at Lower Costs
President Biden issued a pardon for federally incarcerated inmates with minor marijuana possession charges, urging governors to do the same at the state level The President also requested a reclassification of cannabis, as it is…
-
MissionIRNewsBreaks – Freight Technologies Inc. (NASDAQ: FRGT) Eyes Steady Growth, Traction in Distinctive Solutions
Freight Technologies (NASDAQ: FRGT) (“Fr8Tech”) has grown its operations with numerous improvements to its cloud-based marketplace that simplifies the once-complex process of international over-the-road (“OTR”) cross-border shipping. In addition, Fr8Tech is constantly exploring new ways…
-
MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Doses First Patient in Global Berubicin Trial Evaluating GBM Treatment
CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, has provided an update on enrollment of its ongoing…
-
MissionIRNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Eliminates Some $13M in Debt
Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, has eliminated $13 million in company debt, resulting in a reduction of overall indebtedness from more than $30 million last year to less than $10…
-
Lexaria Bioscience Corp. (NASDAQ: LEXX) Maintains Late 2022/Early 2023 for Full IND Application for DehydraTECH-CBD
Lexaria, through its patented DehydraTECH(TM) technology, is improving the bioavailability of pharmaceuticals and therapeutics (in part) by bypassing first-pass-liver processing, thereby achieving an improved speed of onset, and brain absorption of APIs Hypertension currently affects…
-
MissionIRNewsBreaks – Knightscope Inc. (NASDAQ: KSCP) Announces New Contracts, Indicative of Company’s Continued Reach
Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots (“ASRs”), has announced five new contracts. The contracts are with companies across the United States from several different industries. According to the announcement, the companies…
-
MissionIRNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Secures IRB Approval for Human Clinical Nicotine Study
Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced its receipt of independent review board (“IRB”) approval for human clinical nicotine study NIC-H22-1, and that human dosing will begin soon.…
-
MissionIRNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Exec to Present at Neuropsychiatric & Psychedelics Drug Development Summit
Cybin (NEO: CYBN) (NYSE American: CYBN), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics(TM), will be participating in the 5th annual Neuropsychiatric & Psychedelics Drug Development Summit. The summit runs through Nov. 2, 2022, and…
-
Correlate Infrastructure Partners Inc. (CIPI) In Strong Position, as IRA Unleashes Funding Opportunities, and Evidence Shows U.S. Dramatic Turn Toward Renewables
Correlate Infrastructure Partners Inc. is a company that helps commercial real estate industry clients make the transition to climate-friendly energy sources in highly affordable ways Climate friendliness has increasingly occupied the attention of international governments…
-
Mullen Automotive Inc. (NASDAQ: MULN) ‘Strikingly Different’ Test Drive Tour Shines Spotlight on Mullen FIVE
Mullen’s U.S. test drive tour added additional dates, locations based on overwhelming response Tour provides hands-on opportunity to see the Mullen FIVE Second leg of tour, which will feature the Mullen FIVE RS, already in…
-
Flora Growth Corp. (NASDAQ: FLGC) Focusing on Execution and Brand Integration Following Successful Period of Strategic Investment
Flora Growth recently participated in an earnings call in which the management team discussed the company’s financials as well as its growth strategy and outlook for the remainder of fiscal 2022 as well as 2023…
-
MissionIRNewsBreaks – CNS Pharmaceuticals Inc.’s (NASDAQ: CNSP) Berubicin Shows Superior Performance to Other Anthracyclines, Standards of Care for GBM
CNS Pharmaceuticals (NASDAQ: CNSP) is a biopharmaceutical innovator staking out its own position within the competitive field of research, having already progressed to human trials evaluating its novel glioblastoma multiforme (“GBM”) solution, known as Berubicin…
-
MissionIRNewsBreaks – Cepton Inc. (NASDAQ: CPTN) Secures LOI for up to $100M to Help Fund next Stage of Growth
Cepton (NASDAQ: CPTN), a Silicon Valley innovator and pioneer within high-performance lidar solutions, has rapidly emerged as a leader amongst its peers – deploying its unique capabilities across a host of different environments, ranging from…
-
MissionIRNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Shares Responses from Participants of Its Strikingly Different FIVE EV Crossover Tour
Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, is seeing an overwhelmingly positive response to its Strikingly Different FIVE EV Crossover tour. Tour participants, including potential buyers and Mullen investors, who reserve a…
-
Lexaria Bioscience Corp. (NASDAQ: LEXX) Moves to Address Adverse Effects of Hypertension with DehydraTECH(TM) – CBD
Lexaria is a drug delivery technology company developing DehydraTECH-CBD as a prospective registered treatment for hypertension and potentially other disease states beyond hypertension The company has undertaken multiple de-risking hypertension studies that have not only…
Search Articles
Latest Articles
- FAVO Capital Inc. (FAVO): When Private Credit Meets Real Estate Collateralization
- AI and the Copper Conundrum: How Trilogy Metals Inc. (NYSE American: TMQ) (TSX: TMQ) Fits into the Supply Equation
- Silvercorp Metals Inc. (NYSE-A/TSX: SVM) El Domo Environmental License Upheld as Ecuador’s Constitutional Court Dismisses Final Challenge
- NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Seeks FDA Ban on Toxic Ketamine Preservative
- MissionIRNewsBreaks – Calidi Biotherapeutics Inc. (NYSE American: CLDI) Closes $6.9 Million Public Offering Including Full Over-Allotment Option